Currently Available Non-Balloon Devices

Obesity and metabolic syndrome are known to have an impact on the economy. Obesity and metabolic syndrome affect about 40% population in the America alone, and with about 400 million obese adults in the world, obesity is a global concern. Moreover, the prevalence of overweight children is increasing...

Full description

Bibliographic Details
Main Author: Hang Lak Lee
Format: Article
Language:English
Published: Hoon Jai Chun 2018-09-01
Series:Clinical Endoscopy
Subjects:
Online Access:http://www.e-ce.org/upload/pdf/ce-2018-143.pdf
id doaj-25f30bef0b51403dba41cb62d4cb80a6
record_format Article
spelling doaj-25f30bef0b51403dba41cb62d4cb80a62020-11-25T01:05:15ZengHoon Jai ChunClinical Endoscopy2234-24002234-24432018-09-0151541641910.5946/ce.2018.1437147Currently Available Non-Balloon DevicesHang Lak LeeObesity and metabolic syndrome are known to have an impact on the economy. Obesity and metabolic syndrome affect about 40% population in the America alone, and with about 400 million obese adults in the world, obesity is a global concern. Moreover, the prevalence of overweight children is increasing. Bariatric surgery remains the gold standard for the treatment of obesity; however, endoscopic approaches may have a significant role in the management of metabolic syndrome and obesity. Until recently, many endoscopic methods have been introduced; however, few methods are used in practice, whereas others are under experimental research. Endoscopists have an important role in the treatment of obesity because endoscopic therapies have demonstrated their safety and efficacy over the past few years. Endoscopic bariatric therapies can be categorized as follows: space occupying, malabsorption, and gastric volume reduction. In this review, we summarize the currently available non-balloon type endoscopic procedure.http://www.e-ce.org/upload/pdf/ce-2018-143.pdfEndoscopyFDA approvedObesity
collection DOAJ
language English
format Article
sources DOAJ
author Hang Lak Lee
spellingShingle Hang Lak Lee
Currently Available Non-Balloon Devices
Clinical Endoscopy
Endoscopy
FDA approved
Obesity
author_facet Hang Lak Lee
author_sort Hang Lak Lee
title Currently Available Non-Balloon Devices
title_short Currently Available Non-Balloon Devices
title_full Currently Available Non-Balloon Devices
title_fullStr Currently Available Non-Balloon Devices
title_full_unstemmed Currently Available Non-Balloon Devices
title_sort currently available non-balloon devices
publisher Hoon Jai Chun
series Clinical Endoscopy
issn 2234-2400
2234-2443
publishDate 2018-09-01
description Obesity and metabolic syndrome are known to have an impact on the economy. Obesity and metabolic syndrome affect about 40% population in the America alone, and with about 400 million obese adults in the world, obesity is a global concern. Moreover, the prevalence of overweight children is increasing. Bariatric surgery remains the gold standard for the treatment of obesity; however, endoscopic approaches may have a significant role in the management of metabolic syndrome and obesity. Until recently, many endoscopic methods have been introduced; however, few methods are used in practice, whereas others are under experimental research. Endoscopists have an important role in the treatment of obesity because endoscopic therapies have demonstrated their safety and efficacy over the past few years. Endoscopic bariatric therapies can be categorized as follows: space occupying, malabsorption, and gastric volume reduction. In this review, we summarize the currently available non-balloon type endoscopic procedure.
topic Endoscopy
FDA approved
Obesity
url http://www.e-ce.org/upload/pdf/ce-2018-143.pdf
work_keys_str_mv AT hanglaklee currentlyavailablenonballoondevices
_version_ 1725195316295106560